STTCOMP VR1 FA LONGCheck out the company presentation to find out about what they do.Undervalued in my opinion (take a look at the financials). Currently at a four-year low with quarterly coming up which I think will be a positive catalyst.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
